Oncology PracticeThrice yearly cytologic testing may best annual cervical screeningsMay 17, 2019Preventive CareGynecologic Cancer
Oncology PracticeVaginal brachytherapy more toxic than pelvic RT in endometrial carcinomaApril 30, 2019Gynecologic Cancer
Lessons from KEYNOTE-158 and the role of R-CHOPApril 25, 2019Gynecologic CancerB Cell LymphomaImmuno-oncology
Oncology PracticeDecline in CIN2+ in younger women after HPV vaccine introducedApril 18, 2019Gynecologic Cancer
Oncology PracticeIn endometrial cancer and SUI, concomitant surgery improves outcomesApril 11, 2019Gynecologic CancerPatient & Survivor Care
Oncology PracticePembrolizumab benefits some patients with advanced cervical cancerApril 9, 2019Gynecologic Cancer
Oncology PracticeFor endometrial cancer, postop taxane/platinum competes with standard therapyMarch 26, 2019Gynecologic Cancer
Oncology PracticeTisotumab vedotin shows promise in recurrent, metastatic cervical cancerMarch 26, 2019Gynecologic Cancer
Oncology PracticeBrachytherapy access may mediate poor cervical cancer survival in blacksMarch 23, 2019Gynecologic Cancer
Oncology PracticeStudy explores third-line trabectedin plus PLD for BRCA1/2 ovarian cancerMarch 23, 2019Gynecologic Cancer
Oncology PracticeCombo shows promise for endometrial, ovarian cancersMarch 22, 2019Gynecologic Cancer
Oncology PracticeStudy: Racial disparities in gyn-onc trial enrollment persistMarch 22, 2019Gynecologic Cancer
Oncology PracticeARIEL3 analysis: Rucaparib PFS benefit in recurrent OC occurs across age groupsMarch 21, 2019Gynecologic Cancer
Oncology PracticeNeratinib shows promise in HER2-mutant cervical cancerMarch 19, 2019Gynecologic Cancer
Oncology PracticePerceived cancer risk may improve access to HPV vaccineMarch 19, 2019Gynecologic CancerPreventive Care
